BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 30178917)

  • 1. Genome Editing in Mice Using CRISPR/Cas9 Technology.
    Hall B; Cho A; Limaye A; Cho K; Khillan J; Kulkarni AB
    Curr Protoc Cell Biol; 2018 Dec; 81(1):e57. PubMed ID: 30178917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysing the outcome of CRISPR-aided genome editing in embryos: Screening, genotyping and quality control.
    Mianné J; Codner GF; Caulder A; Fell R; Hutchison M; King R; Stewart ME; Wells S; Teboul L
    Methods; 2017 May; 121-122():68-76. PubMed ID: 28363792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
    Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
    Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroporation of mice zygotes with dual guide RNA/Cas9 complexes for simple and efficient cloning-free genome editing.
    Teixeira M; Py BF; Bosc C; Laubreton D; Moutin MJ; Marvel J; Flamant F; Markossian S
    Sci Rep; 2018 Jan; 8(1):474. PubMed ID: 29323173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Editing in Mouse Zygotes Using the CRISPR/Cas9 System.
    Wefers B; Wurst W; Kühn R
    Methods Mol Biol; 2023; 2631():207-230. PubMed ID: 36995669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
    Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
    Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of genetically modified rat models via the CRISPR/Cas9 technology.
    Liu MZ; Wang LR; Li YM; Ma XY; Han HH; Li DL
    Yi Chuan; 2023 Jan; 45(1):78-87. PubMed ID: 36927640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor.
    Kim YS; Kim GR; Park M; Yang SC; Park SH; Won JE; Lee JH; Shin HE; Song H; Kim HR
    Tissue Eng Regen Med; 2020 Feb; 17(1):45-53. PubMed ID: 32002841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Efficient Mouse Genome Editing by CRISPR Ribonucleoprotein Electroporation of Zygotes.
    Chen S; Lee B; Lee AY; Modzelewski AJ; He L
    J Biol Chem; 2016 Jul; 291(28):14457-67. PubMed ID: 27151215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent linkage of the DNA repair template to the CRISPR-Cas9 nuclease enhances homology-directed repair.
    Savic N; Ringnalda FC; Lindsay H; Berk C; Bargsten K; Li Y; Neri D; Robinson MD; Ciaudo C; Hall J; Jinek M; Schwank G
    Elife; 2018 May; 7():. PubMed ID: 29809142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing.
    Tatiossian KJ; Clark RDE; Huang C; Thornton ME; Grubbs BH; Cannon PM
    Mol Ther; 2021 Mar; 29(3):1057-1069. PubMed ID: 33160457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease.
    Qin W; Dion SL; Kutny PM; Zhang Y; Cheng AW; Jillette NL; Malhotra A; Geurts AM; Chen YG; Wang H
    Genetics; 2015 Jun; 200(2):423-30. PubMed ID: 25819794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision genome editing in the CRISPR era.
    Salsman J; Dellaire G
    Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generating Mouse Models Using CRISPR-Cas9-Mediated Genome Editing.
    Qin W; Kutny PM; Maser RS; Dion SL; Lamont JD; Zhang Y; Perry GA; Wang H
    Curr Protoc Mouse Biol; 2016 Mar; 6(1):39-66. PubMed ID: 26928663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions.
    Lo TW; Pickle CS; Lin S; Ralston EJ; Gurling M; Schartner CM; Bian Q; Doudna JA; Meyer BJ
    Genetics; 2013 Oct; 195(2):331-48. PubMed ID: 23934893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.